IP Library Granted Patent US 8,173,665
Granted Patent B2
US 8,173,665 · App. 12/509,936 · Granted May 8, 2012

I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,173,665
App. No.
12/509,936
Granted
May 8, 2012
Kind
B2
Abstract

The invention relates to 4-cyanophenyl, 2-sulfanyl, 1-phenyl pyrimidine derivatives, processes for their preparation, and pharmaceutical compositions of the same. Compounds and compositions of the invention are useful in the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction, and heart failure development.

Claims (73)

1. A compound of formula (I-B)

wherein

A represents a phenyl ring,

R 1 represents hydrogen, halogen, nitro, cyano, C 1 -C 6 -alkyl, hydroxy or C 1 -C 6 -alkoxy, wherein C 1 -C 6 -alkyl and C 1 -C 6 -alkoxy can be further substituted with one to three identical or different radicals selected from the group consisting of halogen, hydroxy and C 1 -C 4 -alkoxy,

R 2 represents para-substituted cyano,

R 3 represents hydrogen,

R 4 represents C 1 -C 6 -alkyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, mono- or di-C 1 -C 4 -alkylaminocarbonyl, C 6 -C 10 -arylaminocarbonyl, heteroarylcarbonyl, heterocyclylcarbonyl, heteroaryl, heterocyclyl or cyano, wherein C 1 -C 6 -alkyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, mono- and di-C 1 -C 4 -alkyl-aminocarbonyl can be further substituted with one to three identical or different radicals selected from the group consisting of C 3 -C 8 -cycloalkyl, hydroxy, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxycarbonyl, hydroxycarbonyl, amino-carbonyl, mono- and di-C 1 -C 4 -alkylaminocarbonyl, C 1 -C 4 -alkylcarbonyl-amino, amino, mono- and di-C 1 -C 4 -alkylamino, heteroaryl, heterocyclyl, tri-(C 1 -C 6 -alkyl)-silyl and cyano,

R 5 represents C 1 -C 4 -alkyl

R 6A represents hydrogen, C 1 -C 6 -alkylcarbonyl, C 3 -C 8 -cycloalkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, mono- or di-C 1 -C 4 -alkylaminocarbonyl, wherein C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, mono- and di-C 1 -C 4 -alkylamino-carbonyl can be substituted with one to three identical or different radicals selected from the group consisting of C 3 -C 8 -cycloalkyl, hydroxy, C 1 -C 4 -alkoxy, amino, mono- and di-C 1 -C 4 -alkylamino,

R 6B represents C 1 -C 6 -alkyl, which can be substituted with one to three identical or different radicals selected from the group consisting of hydroxy, C 1 -C 4 -alkoxy, amino, mono- and di-C 1 -C 4 -alkylamino, C 1 -C 4 -alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, mono- and di-C 1 -C 4 -alkylamino-carbonyl, C 1 -C 4 -alkylcarbonyloxy, aminocarbonyloxy, cyano, aryl, heteroaryl and heterocyclyl, wherein heteroaryl and heterocyclyl can be further substituted with one to two identical or different radicals selected from the group consisting of C 1 -C 4 -alkyl, hydroxy and oxo,

R 7 represents halogen, or C 1 -C 4 -alkyl substituted with one to three identical or different halogen radicals,

and

Y 1 , Y 2 , Y 3 and Y 4 each represent CH.

2. The compound of formula (I-B) according to claim 1 , wherein

A represents a phenyl ring,

R 1 represents hydrogen, halogen, nitro, cyano, C 1 -C 6 -alkyl, hydroxy or C 1 -C 6 -alkoxy, wherein C 1 -C 6 -alkyl and C 1 -C 6 -alkoxy can be further substituted with one to three identical or different radicals selected from the group consisting of halogen, hydroxy and C 1 -C 4 -alkoxy,

R 2 represents para-substituted cyano,

R 3 represents hydrogen,

R 4 represents C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, mono- or di-C 1 -C 4 -alkylaminocarbonyl, C 6 -C 10 -arylaminocarbonyl, heteroarylcarbonyl, heterocyclylcarbonyl, heteroaryl, heterocyclyl or cyano, wherein C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, mono- and di-C 1 -C 4 -alkylaminocarbonyl can be further substituted with one to three identical or different radicals selected from the group consisting of C 3 -C 8 -cycloalkyl, hydroxy, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, mono- and di-C 1 -C 4 -alkylaminocarbonyl, C 1 -C 4 -alkylcarbonylamino, amino, mono- and di-C 1 -C 4 -alkylamino, heteroaryl, heterocyclyl and tri-(C 1 -C 6 -alkyl)-silyl,

R 5 represents C 1 -C 4 -alkyl

R 6A represents hydrogen, C 1 -C 6 -alkylcarbonyl, C 3 -C 8 -cycloalkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, mono- or di-C 1 -C 4 -alkylaminocarbonyl, wherein C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, mono- and di-C 1 -C 4 -alkylaminocarbonyl can be substituted with one to three identical or different radicals selected from the group consisting of C 3 -C 8 -cycloalkyl, hydroxy, C 1 -C 4 -alkoxy, amino, mono- and di-C 1 -C 4 -alkylamino,

R 6B represents C 1 -C 6 -alkyl, which can be substituted with one to three identical or different radicals selected from the group consisting of hydroxy, C 1 -C 4 -alkoxy, amino, mono- and di-C 1 -C 4 -alkylamino, aryl, heteroaryl and heterocyclyl,

R 7 represents halogen or C 1 -C 4 -alkyl, substituted with one to three identical or different halogen radicals,

and

Y 1 , Y 2 , Y 3 and Y 4 each represent CH.

3. The compound of formula (I-B) according to claim 1 , wherein

A represents a phenyl ring,

R 1 represents hydrogen, fluoro, chloro, bromo, nitro, cyano, methyl, ethyl, trifluoromethyl or trifluoromethoxy,

R 2 represents para-substituted cyano,

R 3 represents hydrogen,

R 4 represents C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, hydroxycarbonyl, aminocarbonyl, mono- or di-C 1 -C 4 -alkylaminocarbonyl or cyano, wherein C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl and mono-C 1 -C 4 -alkylaminocarbonyl can be substituted with one to three identical or different radicals selected from the group consisting of C 3 -C 6 -cycloalkyl, hydroxy, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxycarbonyl, amino, mono- or di-C 1 -C 4 -alkylamino, heteroaryl and heterocyclyl,

R 5 represents methyl or ethyl,

R 6A represents hydrogen, C 1 -C 6 -alkylcarbonyl or C 3 -C 6 -cycloalkylcarbonyl, wherein C 1 -C 6 -alkylcarbonyl can be substituted with a radical selected from the group consisting of C 3 -C 6 -cycloalkyl, hydroxy, C 1 -C 4 -alkoxy, amino, mono- and di-C 1 -C 4 -alkylamino,

R 6B represents C 1 -C 6 -alkyl, which can be substituted with a radical selected from the group consisting of hydroxy, C 1 -C 4 -alkoxy, amino, mono- and di-C 1 -C 4 -alkylamino, phenyl, heteroaryl and heterocyclyl,

R 7 represents halogen, trifluoromethyl, or trifluoromethoxy,

and

Y 1 , Y 2 , Y 3 and Y 4 each represent CH.

4. The compound of formula (I-B) according to claim 1 , wherein

A represents a phenyl ring,

R 1 and R 3 each represent hydrogen,

R 2 represents para-substituted cyano,

R 4 represents C 1 -C 4 -alkylcarbonyl or C 1 -C 4 -alkoxycarbonyl, wherein C 1 -C 4 -alkoxycarbonyl can be substituted with a radical selected from the group consisting of hydroxy, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxycarbonyl, mono- and di-C 1 -C 4 -alkylamino, heteroaryl and heterocyclyl,

R 5 represents methyl,

R 6A represents hydrogen, C 1 -C 6 -alkylcarbonyl or C 3 -C 6 -cycloalkylcarbonyl,

R 6B represents C 1 -C 4 -alkyl, which can be substituted with a radical selected from the group consisting of hydroxy, C 1 -C 4 -alkoxy, amino, di-C 1 -C 4 -alkylamino, phenyl, pyridyl, imidazolyl, pyrrolidino and morpholino,

R 7 represents trifluoromethyl,

and

Y 1 , Y 2 , Y 3 and Y 4 each represent CH.

5. The compound of formula (I-B) according to claim 1 , where wherein R 1 is hydrogen.

6. The compound of formula (I-B) according to claim 1 , wherein R 5 is methyl.

7. The compound of formula (I-B) according to claim 1 , wherein R 7 is trifluoromethyl.

8. The compound of formula (I-B) according to claim 1 , wherein R 6B is methyl, (1H-imidazol-2-yl)methyl, 2-(diethylamino)ethyl, 2-hydroxyethyl, 3-hydroxypropyl and 2-(1-pyrrolidinyl)ethyl.

9. A compound of formula (I-E)

wherein

Z represents CH,

R 1 , R 3 and R 4 have the meaning indicated in claim 1 , and

R 6B represents C 1 -C 4 -alkyl, which can be substituted with a radical selected from the group consisting of hydroxy, di-C 1 -C 4 -alkylamino, phenyl, pyridyl, imidazolyl, pyrrolidino and morpholino.

10. A process for synthesizing a compound of formula (I-B) or (I-E), as defined in claim 1 , by condensing a compound of formula (II)

wherein A, R 1 and R 2 have the meaning indicated in claim 1 or 9 ,

with a compound of formula (III)

wherein R 4 and R 5 have the meaning indicated in claim 1 or 9 ,

and a compound of formula (IV)

wherein R 3 , R 7 , and Y 1 to Y 4 have the meaning indicated in claim 1 or 9 ,

in the presence of an acid either in a three-component/one-step reaction or sequentially to give a compound of formula (I-D)

wherein

A, R 1 to R 5 , R 7 , and Y 1 to Y 4 have the meaning indicated in claim 1 or 9 ,

followed by reaction of a compound of formula (I-D) in the presence of a base

with a compound of formula (VI)

R 6B—X B   (VI),

wherein R 6B has the meaning indicated in claim 1 or 9 , and X B represents a leaving group

to give a compound of formula (I-B) or (I-E).

11. A composition containing at least one compound of formula (I-B) or (I-E), as defined in claim 1 or 9 , and a pharmacologically acceptable diluent.

12. A process for the preparation of a composition according to claim 11 characterized in that the compounds of general formula (I-B) or (I-E), as defined in claim 1 or 9 , together with customary auxiliaries are brought into a suitable application form.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029908/0437 →